Department of Biomedical Informatics
-
September 8, 2022
Simple Beginnings
Vanderbilt held its annual Simple Beginnings ceremony for new doctoral students last week in Light Hall. -
August 2, 2022
Targeted cancer drug during pregnancy
The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians. -
July 21, 2022
VUMC partners with Yale and Morehouse Schools of Medicine, industry organizations to increase diversity in clinical trials
Vanderbilt is partnering with Yale School of Medicine, Morehouse School of Medicine and the Research Centers in Minority Institutions Coordinating Center at the Morehouse School of Medicine in an initiative aimed at boosting participation in clinical trials. -
July 14, 2022
Study explores clinical uses for polygenic risk scores
Vanderbilt University Medical Center has received a five-year, $4.5 million grant from the National Human Genome Research Institute to assess clinical outcomes and economic value of screening large, diverse health care populations for disease risk using polygenic risk scores. -
June 16, 2022
Researchers add sign language videos to electronic surveys
A new external module in Vanderbilt's REDCap improves electronic survey accessibility for respondents who are deaf. The module makes it easy to embed individual sign language videos for each survey question and answer. -
June 15, 2022
Chancellor Faculty Fellows announced
Several highly accomplished, recently tenured faculty from a wide variety of disciplines and areas of expertise have been selected for the 2022 cohort of Chancellor Faculty Fellows. -
May 25, 2022
Study seeks to improve gender equity for liver transplantation waiting list
Women who need a liver transplant are more likely to spend more time on a waiting list, become too sick for transplant or die compared to men. To improve equity, a recently published Vanderbilt-led study suggests a sex adjustment to criteria for MELD (model for end-stage liver disease), which determines allocation of transplanted livers.